Innovative Breakthrough: Glumetinib Ushers in a New Era of...

ha añadido un blog Wellness

2026-01-04 09:46:26 - Traducir

Innovative Breakthrough: Glumetinib Ushers in a New Era of Precision Treatment for Lung Cancer

DengyueMed Report: China's National Medical Products Administration has conditionally approved a milestone antitumor new drug—Glumetinib Tablets (trade name: Haiyitan®)—for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) harboring MET exon 14 skipping (METex14 skipping). This breakthrough advancement marks a key step in...

0 Commentarios 0 Veces compartido 715 Visualizaciones